BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang Z, Zheng CQ. Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports. World J Clin Cases 2022; 10(29): 10550-10558 [PMID: 36312501 DOI: 10.12998/wjcc.v10.i29.10550]
URL: https://www.wjgnet.com/2307-8960/full/v10/i29/10550.htm
Number Citing Articles
1
Camrelizumab/sintilimabReactions Weekly 2023; 1950(1): 104 doi: 10.1007/s40278-023-36501-y